tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Matthew Keller, 16 are a BUY (100%).
Analyst Matthew Keller, carries an average stock price target met ratio of 16.67% that have a potential upside of 64.73% achieved within 56 days.
Matthew Keller’s has documented 30 price targets and ratings displayed on 6 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on GRI, GRI Bio at 10-Sep-2026.
Analyst best performing recommendations are on SNSE (SENSEI BIOTHERAPEUTICS).
The best stock recommendation documented was for SNSE (SENSEI BIOTHERAPEUTICS) at 8/5/2025. The price target of $30 was fulfilled within 199 days with a profit of $21.76 (264.08%) receiving and performance score of 13.27.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 02-Jul-2025
$10
$7.95 (387.80%)
$280.11
19 days ago
(10-Sep-2026)
0/2 (0%)
$8.06 (415.46%)
Buy Since 05-Dec-2024
$36
6 months 18 days ago
(11-Mar-2026)
5/5 (100%)
$-1.8 (-4.76%)
53
Buy Since 09-Dec-2024
$10
$7.95 (387.80%)
$10
1 years 3 months 18 days ago
(11-Jun-2025)
3/3 (100%)
$-26.96 (-72.94%)
178
Which stock is Matthew Keller most bullish on?
Which stock is Matthew Keller most reserved on?
